VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

ISLB 2022 | Future directions of liquid biopsy for breast cancer

Nicola Fusco, MD, European Institute of Oncology (IEO), Milan, Italy, discusses the need for comprehensive guidelines for the use of liquid biopsy and the importance of conducting validation studies across the range of liquid biopsy technologies available. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Consulting/advisory role: Novartis, AstraZeneca, Diaceutics, Adicet Bio, Sermonix
Speaker bureau: MSD, Boehringer Ingelheim, Novartis, AstraZeneca, Daiichi Sankyo, GSK, Gilead, Diaceutics
Research grants: Novartis, Reply

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter